Stiff Competition: The generic drug industry competes with original branded drugs. When a branded drug loses exclusivity, generic competition intensifies as rivals undercut prices.

The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion ...

Several smaller companies also develop generic versions of branded drugs, significantly cheaper than original drugs. Competition in this segment is stiff, resulting in thin margins for ...

Biosimilar drugs are drugs that are a lot like biologics, but maybe not identical. Learn why this matters inside.

A debate on patented vs. generic drugs continues. While branded drugs like Dolo 650 gain trust through marketing, generics offer the same benefits at lower costs.

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects ...

The law had two primary goals: to facilitate the entry of generic drugs into the market and to compensate original drug developers for regulatory delays by the Food and Drug Administration.

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to controversial practices around the sale of compounded drugs. These drugs are ...

The FDA has approved one generic GLP-1 drug that’s in the same drug class as Wegovy. This generic GLP-1 is liraglutide for injection (the generic version of Victoza).

A generic drug is a drug in which the patent term relating to the active ingredient has expired. Under the Pharmaceutical Affairs Act, the approval of the Ministry of Health, Labour and Welfare (the ...